Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Other 1

Conditions

Carcinoma, Non-Small-Cell Lung 92Lung Neoplasms 32NSCLC 7Brain Neoplasms 7Meningeal Carcinomatosis 4Neoplasm Metastasis 3Carcinoma, Squamous Cell 2Bronchial Neoplasms 2Adenocarcinoma of Lung 2Small Cell Lung Carcinoma 1Sexual Dysfunction, Physiological 1Resectable Non-small Cell Lung Cancer 1Rare Tumour 1Prostatic Neoplasms 1Progression Free Survival 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Non-small Cell Carcinoma 1Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (Disorder) 1Non-Small Cell Lung Cancer With EGFR T790M Mutation 1Non-Small Cell Lung Cancer With EGFR Mutation 1Non Small Cell Lung Cancer Metastatic 1Neurocognitive 1Neoplastic Cells, Circulating 1Neoplasm, Residual 1Lung Cancer Metastatic 1Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC) 1Glioblastoma 1Eunuchism 1Erectile Dysfunction 1

Interventions

Sildenafil Citrate 8Tadalafil 2Surveys and Questionnaires 2Alprostadil 2udenafil 1trametinib 1sotorasib 1selpercatinib 1pembrolizumab 1osimertinib 1mirabegron 1methyl 3-mercaptopropionimidate 1lorlatinib 1dabrafenib 1cemiplimab 1brigatinib 1bicalutamide 1alpha-Tocopherol 1alectinib 1Vitamin E 1Tamoxifen 1Surgical Instruments 1Saline Solution 1Restraint, Physical 1Psychiatric Rehabilitation 1Preservation, Biological 1Pentoxifylline 1Pemetrexed 1Paclitaxel 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Erectile Dysfunction × osimertinib × Clear all
NCT06532149 2024-08-09

EROS

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Recruiting
80 enrolled
OtherThoracic

Carcinoma, Non-Small-Cell Lung, Eunuchism, Erectile Dysfunction, Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡